undamentalytics Newsletter
Sign in

Idexx Laboratories balance sheet

At the end of fiscal 2025, Idexx Laboratories had total assets of $3.35bn, total liabilities of $1.75bn and shareholders' equity of $1.61bn. It held $180m in cash against $848m of debt: net debt of $668m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash and equivalents10715718422427932312915518812490384144113454288180198
Receivables115120141138158152188204237249269331368401457474552616
Inventory110128133141133160189158163173195210269368380382378391
Total current assets3764615245706537598228469726536801,0639561,1011,4951,4001,4141,500
Goodwill149149173175181184179178200214240243359362366405414641
Total assets8098971,0311,1041,2311,3841,4751,5311,7421,6201,8322,2952,4372,7473,2603,2933,3513,707
Accounts payable192337353045536067707275116110111114110154
Deferred revenue (current)131415202132262729414143403837343540
Total current liabilities2562854374064788218579351,0057847255837641,2369521,0681,1491,264
Short-term debt——————————0507575751687575
Long-term debt——33151350597594607602699858775694623450375300
Total debt1231322462154288991,1701,2056076029889099241,020948868848849
Total liabilities2943234914677121,2671,5591,6391,8011,6291,6551,6621,7472,1381,7751,6981,7451,838
Shareholders' equity515574540636518118−84−108−59−101776326906091,4851,5951,6051,869
Net debt (negative = net cash)16−2463−91495761,0411,050419478898525780907494580668651
Shares outstanding—————95m——87m86m85m85m85m83m83m82m80m79m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: DXCM vs IDXXBLCO vs IDXXIDXX vs RMD

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Idexx Laboratories's SEC filings (10-K and 10-Q), retrieved November 2, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Idexx Laboratories.